In this issue of The Lancet Infectious Diseases, Tobias Broger and colleagues evaluated a new urine-based point-of-care test for detecting urine lipoarabinomannan. The assay is called Fujifilm SILVAMP TB LAM assay (FujiLAM; FujiFilm, Tokyo, Japan).
Please see the evaluation paper and the accompanying editorial by Drain et al.
Broger LID 2019.pdf (723.5 KB)
Drain LID 2019.pdf (135.6 KB)